Surgical resection after downsizing of colorectal liver metastasis in the era of bevacizumab

被引：138

作者：

Ellis, LM

Curley, SA

Grothey, A

机构：

[1] Univ Texas, MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA

[2] Univ Texas, MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA

[3] Mayo Clin, Div Med Oncol, Rochester, MN USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 22期

关键词：

D O I：

10.1200/JCO.2005.23.754

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：4853 / 4855

页数：3

共 26 条

[1] Chemotherapy and surgery: new perspectives on the treatment of unresectable liver metastases [J].

Adam, R .

ANNALS OF ONCOLOGY, 2003, 14 :13-16

[2] Tumor progression while on chemotherapy - A contraindication to liver resection for multiple colorectal metastases? [J].

Adam, R ;

Pascal, G ;

Castaing, D ;

Azoulay, D ;

Delvart, V ;

Paule, B ;

Levi, F ;

Bismuth, H .

ANNALS OF SURGERY, 2004, 240 (06) :1052-1064

[3]

Adam R, 2004, ANN SURG, V240, P644, DOI 10.1097/01.sla.0000141198.92114.16

[4] Effect of vascular endothelial growth factor on hepatic regenerative activity following partial hepatectomy in rats [J].

Assy, N ;

Spira, G ;

Paizi, M ;

Shenkar, L ;

Kraizer, Y ;

Cohen, T ;

Neufeld, G ;

Dabbah, B ;

Enat, R ;

Baruch, Y .

JOURNAL OF HEPATOLOGY, 1999, 30 (05) :911-915

[5]

Brook R H, 1986, Int J Technol Assess Health Care, V2, P53

[6] Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer [J].

Cunningham, D ;

Humblet, Y ;

Siena, S ;

Khayat, D ;

Bleiberg, H ;

Santoro, A ;

Bets, D ;

Mueser, M ;

Harstrick, A ;

Verslype, C ;

Chau, I ;

Van Cutsem, E .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (04) :337-345

[7]

Fitch K, 2001, RAND UCLA APPROPRIAT

[8] Chronobiology of the proliferative events related to angiogenesis in mice liver regeneration after partial hepatectomy [J].

Furnus, CC ;

Inda, AM ;

Andrini, LB ;

García, MN ;

García, AL ;

Badrán, AF ;

Errecalde, AL .

CELL BIOLOGY INTERNATIONAL, 2003, 27 (04) :383-386

[9] Phase I safety and pharmacokinetic study of recombinant human anti-vascular endothelial growth factor in patients with advanced cancer [J].

Gordon, MS ;

Margolin, K ;

Talpaz, M ;

Sledge, GW ;

Holmgren, E ;

Benjamin, R ;

Stalter, S ;

Shak, S ;

Adelman, DC .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (03) :843-850

[10]

HALLER DG, 2005, P 2005 GASTR CANC S

← 1 2 3 →